MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
1557.11%
Quick Ratio
1552.74%
Cash Ratio
69.45%
Debt to Asset Ratio
9.83%
Unit: Thousand (K) dollars
Assets Breakdown
    • Investment securities, amortized...
    • Cash and cash equivalents
    • Operating lease right-of-use ass...
    • Others
Liabilities Breakdown
    • Common stock and paid-in capital...
    • Accumulated deficit
    • Accounts payable and accrued exp...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
55,498
114,341
101,536
110,901
Restricted cash
-
-
0
500
Investment securities, amortized cost of 1,153,283 at june 30, 2026 and 924,317 at december 31, 2025
1,150,275
1,176,965
926,353
981,390
Trade accounts receivable, net
11,957
5,683
592
-
Inventory
3,488
3,064
2,022
-
Prepaid expenses and other current assets
23,144
22,361
17,839
28,484
Total current assets
1,244,362
1,322,414
1,048,342
1,121,275
Property and equipment, net
13,073
13,497
14,296
14,377
Operating lease right-of-use assets
39,107
39,790
40,492
41,147
Restricted cash, net of current portion
800
800
800
800
Prepaid expenses and other assets, net of current portion
24,541
24,822
22,327
18,432
Total assets
1,321,883
1,401,323
1,126,257
1,196,031
Accounts payable and accrued expenses
42,439
37,487
41,770
33,674
Accrued compensation and related expenses
29,222
25,792
35,578
32,398
Deferred revenue
1,669
1,271
1,235
1,642
Operating lease liabilities
6,585
6,536
6,489
6,441
Total current liabilities
79,915
71,086
85,072
74,155
Operating lease liabilities, non-current
40,606
41,319
42,052
42,703
Deferred revenue, non-current
3,465
3,346
3,810
4,110
Other liabilities
5,935
4,926
3,240
2,894
Total liabilities
129,921
120,677
134,174
123,862
Common stock and paid-in capital, 0.001 par 200,000 shares authorized 105,808 shares issued and outstanding at june 30, 2026 95,575 shares issued and outstanding at december 31, 2025
2,862,360
2,828,204
2,407,757
2,364,699
Accumulated other comprehensive (loss) income
-3,008
-1,254
1,865
2,194
Accumulated deficit
-1,666,127
-1,545,272
-1,417,427
-1,294,612
Stock held in trust
1,263
1,032
112
112
Total stockholders equity
1,191,962
1,280,646
992,083
1,072,169
Total liabilities and stockholders equity
1,321,883
1,401,323
1,126,257
1,196,031
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Investment securities,amortized cost of...$1,150,275K (0.67%↑ Y/Y)Cash and cashequivalents$55,498K (3.30%↑ Y/Y)Prepaid expenses andother current assets$23,144K (13.43%↑ Y/Y)Trade accountsreceivable, net$11,957K Inventory$3,488K Total current assets$1,244,362K (2.23%↑ Y/Y)Operating leaseright-of-use assets$39,107K (-6.67%↓ Y/Y)Prepaid expenses andother assets, net of...$24,541K (64.29%↑ Y/Y)Property and equipment,net$13,073K (-10.89%↓ Y/Y)Restricted cash, net ofcurrent portion$800K (0.00%↑ Y/Y)Total assets$1,321,883K (2.51%↑ Y/Y)Total liabilities andstockholders equity$1,321,883K (2.51%↑ Y/Y)Total stockholdersequity$1,191,962K (1.74%↑ Y/Y)Total liabilities$129,921K (10.06%↑ Y/Y)Accumulated deficit-$1,666,127K (-43.07%↓ Y/Y)Accumulated othercomprehensive (loss) income-$3,008K (-285.56%↓ Y/Y)Stock held in trust$1,263K (1027.68%↑ Y/Y)Common stock andpaid-in capital, 0.001...$2,862,360K (22.61%↑ Y/Y)Total currentliabilities$79,915K (16.84%↑ Y/Y)Operating leaseliabilities, non-current$40,606K (-6.28%↓ Y/Y)Other liabilities$5,935K (154.28%↑ Y/Y)Deferred revenue,non-current$3,465K (-13.20%↓ Y/Y)Accounts payable andaccrued expenses$42,439K (11.43%↑ Y/Y)Accrued compensationand related...$29,222K (34.07%↑ Y/Y)Operating leaseliabilities$6,585K (-0.38%↓ Y/Y)Deferred revenue$1,669K (-12.34%↓ Y/Y)

Crinetics Pharmaceuticals, Inc. (CRNX)

Crinetics Pharmaceuticals, Inc. (CRNX)